Medicenna Therapeutics Corp. (MDNAF)

OTC Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT05086692 A Beta-only IL-2 ImmunoTherapY Study PHASE2 Recruiting 115

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for MDNAF.

SEC EDGAR Filings

All SEC filings for Medicenna Therapeutics Corp. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.